FEBS Open BioMicrobiologyPeer-reviewed journal article
Mycobacterial cell division arrest and smooth-to-rough envelope transition using CRISPRi-mediated genetic repression systems
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël MazieroiD, Céline CrausteiD, Stéphane CanaaniD, Pierre SantucciiD
Abstract
The genetic basis underlying non-tuberculous mycobacteria (NTM) pathogenesis remains poorly understood. This gap in knowledge has been partially filled over the years through the generation of novel and efficient genetic tools, including the recently developed CRISPR interference (CRISPRi) technology. Our group recently capitalized on the well-established mycobacteria-optimized dCas9Sth1-mediated gene knockdown system to develop a new subset of fluorescence-based CRISPRi vectors that enable simultaneous controlled genetic repression and fluorescence imaging. In this Research Protocol, we use the model organism Mycobacterium smegmatis (M. smegmatis) as surrogate for NTM species and provide simple procedures to assess CRISPRi effectiveness. We describe how to evaluate the efficacy of gene-silencing when targeting essential genes but also genes involved in smooth-to-rough envelope transition, a critical feature in NTM pathogenesis. This protocol will have a broad utility for mycobacterial functional genomics and phenotypic assays in NTM species.
- organism: bacteria (other)
- assay: CRISPR screen
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: perturbation response prediction
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 39th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fluorescence-based CRISPR interference system for controlled genetic repression and live single-cell imaging in mycobacteria
Janïs Laudouze, Vanessa Point, … Pierre Santucci·FEBS LettersPeer-reviewed·Dec 1, 2024
- An Alternative, Cas12a-based CRISPR Interference System for Mycobacteria
Neil D. Fleck, Christoph Grundner·Journal of Biological ChemistryPeer-reviewed·Jul 21, 2021
- Arrayed CRISPRi and Quantitative Imaging Describe the Morphotypic Landscape of Essential Mycobacterial Genes
T. J. de Wet, K. R. Winkler, … D. F. Warner·bioRxiv·Mar 20, 2020
- Development of inducible genetic systems to finely tune efficacy of InhA-targeting anti-tuberculous drugs
Eliana Sepulveda Ramos, Maria Sofia Deschutter, … Pierre Santucci·bioRxiv·Oct 7, 2026
- CRISPRi-mediated validation of candidate Myocobacterium abscessus drug targets during host infection
Rashmi Gupta, Breven S. Simcox, Kyle H. Rohde·bioRxiv·Dec 17, 2025
- CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
Matthew B. McNeil, Laura M. Keighley, … Gregory Murray Cook·Molecular MicrobiologyPeer-reviewed·Aug 4, 2021